Every SEC Form 3/4/5 on record for this filer (CIK 1568077) — 7 issuers, 55 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| KROS | Keros Therapeutics, Inc. | Director | 2020-04-07 → 2025-10-17 | 12 | $7M |
| ELOX | Eloxx Pharmaceuticals, Inc. | Director · lapsed | 2018-03-23 → 2023-01-31 | 10 | $13M |
| LOGC | LogicBio Therapeutics, Inc. | Director · lapsed | 2018-10-18 → 2019-12-20 | 4 | $4M |
| ETNB | 89bio, Inc. | Director · lapsed | 2019-11-08 → 2019-11-13 | 2 | — |
| VBIV | VBI Vaccines Inc/BC | Director · lapsed | 2018-01-29 → 2019-02-04 | 4 | $2M |
| SVOND | Eloxx Pharmaceuticals, Inc. | Director · lapsed | 2017-12-29 → 2017-12-29 | 1 | — |
| ARNI | Arno Therapeutics, Inc | Director · lapsed | 2016-01-14 → 2016-09-08 | 5 | $1M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| ELOX | 2021-05-13 | Buy | 592,592 | $1.35 | $799,999 | 616,592 |
| ELOX | 2021-05-13 | Buy | 1,422,222 | $1.35 | $2M | 1,989,551 |
| ELOX | 2021-05-13 | Buy | 2,630,487 | $1.35 | $4M | 3,679,797 |
| ELOX | 2021-05-13 | Buy | 1,280,624 | $1.35 | $2M | 1,791,470 |
| KROS | 2020-04-13 | Buy | 194,203 | $16.00 | $3M | 2,261,517 |
1 of 7 issuers are covered and open a security page; the rest are on file here only.
